RDM1

Across TCGA pan-cancer cohorts, RDM1 RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of RDM1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RDM1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RDM1 is over-expressed in tumor.

BLCA, KIRC, and KIRP are the cancer types where RDM1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RDM1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	III,IV	+2.282	<.001	12	view →
KIRC	Female	II,III,IV	+0.540	<.001	12	view →
KIRP	All	II,III,IV	+1.302	<.001	11	view →
HNSC	Male	III,IV	+0.789	<.001	11	view →
THCA	Female	II,III,IV	+0.527	<.001	10	view →
LUAD	All	III,IV	+1.045	<.001	9	view →
LIHC	Male	All	+0.841	<.001	9	view →
LUSC	Male	II,III,IV	+1.346	<.001	8	view →
UCEC	All	II,III,IV	+1.285	<.001	8	view →
STAD	All	II,III,IV	+1.030	<.001	8	view →
COAD	Male	All	+0.826	<.001	8	view →
BRCA	All	III,IV	+1.226	<.001	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

RDM1–BLCA

Open the BLCA breakdown →